The University of British Columbia
$366,946.00 CAD
≈ 5 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2023-2024
- Agreement period
- March 14, 2024 – March 1, 2025
- Reference
- nrc-cnrc:172-2023-2024-Q4-1014773
Published purpose
The project will lead to an improved and more cost-effective AAV-LPL gene therapy for the treatment of Lipoprotein Lipase (LPL) Deficiency. The previous limitations of the high costs of production of advanced biologics, such as Glybera, will be addressed through new cost-effective manufacturing in Canada. The project will develop a further optimized AAVbased gene therapy for the treatment of LPL Deficiency as a pilot demonstration of a cost-effective production strategy for new advanced gene therapeutics in Canada
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions